Page last updated: 2024-11-07

2-acetylaminofluorene and Dilatation, Pathologic

2-acetylaminofluorene has been researched along with Dilatation, Pathologic in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
"After 20 weeks cysts were observed in the majority of rats."5.28Experimental liver cysts induced by 2-acetylaminofluorene. ( Itoshima, T; Mizutani, S; Tsuji, T, 1991)
"After 20 weeks cysts were observed in the majority of rats."1.28Experimental liver cysts induced by 2-acetylaminofluorene. ( Itoshima, T; Mizutani, S; Tsuji, T, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizutani, S1
Itoshima, T1
Tsuji, T1

Other Studies

1 other study available for 2-acetylaminofluorene and Dilatation, Pathologic

ArticleYear
Experimental liver cysts induced by 2-acetylaminofluorene.
    Gastroenterologia Japonica, 1991, Volume: 26, Issue:2

    Topics: 2-Acetylaminofluorene; Animals; Bile Ducts; Chemical and Drug Induced Liver Injury; Cysts; Dilatatio

1991